Christoph Huber

About

Christoph Huber is a clinical oncologist, consultant and, successful entrepreneur, recently gaining media attention as a co-founder and board member of BioNTech. In his role as a leading international expert in translational tumour immunology, he has not only published groundbreaking research, but has also always worked to build upon these results, be it by establishing networks of experts or companies. Among other things, he has founded the Association for Cancer Immunotherapy CIMT and is a co-founder, board member and advisor of numerous other research networks and companies.

Source (opens in a new tab)